3 independently checked trend briefs about this subject, newest first.
headlinez.news detected 3 source-qualified news clusters connected to Merck between June 30, 2026 and July 24, 2026. They span 1 newsroom category and average 14.0 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
Merck is establishing voluntary licensing agreements and expanded access programs to prepare for the potential launch of a monthly oral HIV prevention pill.
The FDA has granted approval for Lipfendra, the first oral PCSK9 cholesterol-lowering treatment developed by Merck.
A US House committee has launched an investigation into pharmaceutical companies regarding clinical trial sites located in China.